168 related articles for article (PubMed ID: 32756049)
1. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Guo WW; Chen LH; Yin W; Mo LX
Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
[TBL] [Abstract][Full Text] [Related]
2. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
3. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
[TBL] [Abstract][Full Text] [Related]
4. [Expression of mTOR and 4E-BP1 in extranodal Nasal-type NK/T-cell Lymphoma and implication for prognosis].
Zhang Q; Liu G; Hang W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):123-127. PubMed ID: 30808136
[No Abstract] [Full Text] [Related]
5. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
6. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
Devins K; Schuster SJ; Caponetti GC; Bogusz AM
Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of p-ATM/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis.
Ye Q; Chen H; Wen Z; Guo W; Huang Y; Mo X
J Clin Pathol; 2021 Apr; 74(4):223-227. PubMed ID: 32220941
[TBL] [Abstract][Full Text] [Related]
9. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.
Liang L; Nong L; Zhang S; Zhao J; Ti H; Dong Y; Zhang B; Li T
J Exp Clin Cancer Res; 2014 Jan; 33(1):7. PubMed ID: 24438193
[TBL] [Abstract][Full Text] [Related]
10. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
[TBL] [Abstract][Full Text] [Related]
11. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
12. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.
Fried I; Artl M; Cota C; Müller H; Bartolo E; Boi S; Chiarelli C; Vale E; Schmuth M; Wiesner T; Speicher MR; Cerroni L
J Am Acad Dermatol; 2014 Apr; 70(4):716-723. PubMed ID: 24433873
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
15. Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.
Yu BH; Shui RH; Sheng WQ; Wang CF; Lu HF; Zhou XY; Zhu XZ; Li XQ
PLoS One; 2016; 11(8):e0161831. PubMed ID: 27564014
[TBL] [Abstract][Full Text] [Related]
16. Serum B-cell activating factor predicts prognosis in nasal type, extranodal NK/T cell lymphoma.
Zhang L; Li N; Yang L; Zhang J; Weng HW; Zou LQ
Cytokine; 2016 Dec; 88():196-198. PubMed ID: 27668971
[TBL] [Abstract][Full Text] [Related]
17. Extranodal natural killer/T-cell lymphoma, nasal type, in Senegal.
Diallo M; Diop A; Diatta BA; Ndiaye M; Ortonne N; Dieng MT
Int J Dermatol; 2018 Apr; 57(4):401-405. PubMed ID: 29380871
[TBL] [Abstract][Full Text] [Related]
18. Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Nagato T; Ohkuri T; Ohara K; Hirata Y; Kishibe K; Komabayashi Y; Ueda S; Takahara M; Kumai T; Ishibashi K; Kosaka A; Aoki N; Oikawa K; Uno Y; Akiyama N; Sado M; Takei H; Celis E; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2017 Jul; 66(7):877-890. PubMed ID: 28349165
[TBL] [Abstract][Full Text] [Related]
19. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
[TBL] [Abstract][Full Text] [Related]
20. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
